Allmed Medical Products Co., Ltd

SZSE:002950.SZ

9.17 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q4
Revenue 863.059830.169741.806732.313591.568612.076814.6421,143.341932.7331,141.389993.039598.302830.658676.013820.582745.753833.221,657.967597.558640.889616.897580.567514.109579.756545.582495.787406.387438.072
Cost of Revenue 638.467612.328531.565591.229433.53441.88542766.315640.9709.941676.695375.444625.431477.11566.067497.31471.828881.751383.985415.529399.336390.485349.993375.306383.072348.516284.343371.173
Gross Profit 224.592217.841210.242141.084158.038170.196272.642377.027291.834431.448316.344222.859205.227198.903254.515248.443361.392776.216213.573225.36217.561190.082164.116204.45162.51147.271122.04466.899
Gross Profit Ratio 0.260.2620.2830.1930.2670.2780.3350.330.3130.3780.3190.3720.2470.2940.310.3330.4340.4680.3570.3520.3530.3270.3190.3530.2980.2970.30.153
Reseach & Development Expenses 19.04618.71418.4616.94222.02416.21321.82462.09914.28114.08217.27236.47618.3218.96430.81768.81320.16119.4629.6914.77117.439.05918.45319.60211.1647.34911.6240
General & Administrative Expenses 0-37.83965.033-193.839218.481-56.09790.81-205.776234.98-33.492102.927-152.985185.981-39.59172.778-125.60859.834-25.48552.467-99.47855.487-24.69448.303-82.37242.24141.36537.7580
Selling & Marketing Expenses 024.7618.74920.59313.7068.66322.736.50225.14333.39418.75827.94914.79817.64614.08-70.09447.22629.74131.33234.4331.00235.62129.06235.86329.01125.57622.420
SG&A 104.84981.25183.07175.504232.187-47.434113.54-199.275260.123-0.098121.685-125.036200.779-21.94686.858-195.703107.064.25783.799-65.04986.48810.92777.365-46.50971.25266.94160.1770
Other Expenses -2.2610.226-0.685-81.3660.0130.528-0.017261.362-143.782136.39-5.0430.753-1.053-0.037-0.0470.238-1.1260.498-2.7267.029-2.2160.285-1.487-0.519-1.1660.509-0.0350
Operating Expenses 126.15599.738102.216173.812119.858100.498135.347124.187130.622150.374133.914152.63996.30490.14584.1543.63119.471107.08483.453113.98790.29285.04392.29493.179.48274.41173.6940.146
Operating Income 98.437118.102108.026-32.728-0.00447.628149.456257.89520.918159.257196.322104.73108.103148.413144.628213.795299.158722.118106.711123.12127.23670.60569.583100.76871.29254.45451.08166.899
Operating Income Ratio 0.1140.1420.146-0.045-00.0780.1830.2260.0220.140.1980.1750.130.220.1760.2870.3590.4360.1790.1920.2060.1220.1350.1740.1310.110.1260.153
Total Other Income Expenses Net 0.4787.5653.933-4.4990.0130.528-0.167-22.261-123.926-1.701-1.5990.753-1.87339.619-0.0479.2256.11153.483-26.13618.777-2.248-34.15-3.726-11.102-12.901-17.8972.6960.146
Income Before Tax 98.915125.667111.959-37.2270.00948.156149.288235.635-103.008157.556194.723105.483107.05148.376144.581214.033298.031722.616103.984130.15125.0270.8968.096100.24970.12654.96351.04667.045
Income Before Tax Ratio 0.1150.1510.151-0.05100.0790.1830.206-0.110.1380.1960.1760.1290.2190.1760.2870.3580.4360.1740.2030.2030.1220.1320.1730.1290.1110.1260.153
Income Tax Expense 16.92127.36620.53512.4689.82220.1522.38427.735-9.74926.41635.8544.3916.1825.71527.24514.28948.779101.63713.49722.64719.10114.93813.27214.13416.1399.24310.55813.276
Net Income 78.16993.11893.879-40.005-6.63429.155127.885209.925-93.259132.38157.718102.08391.363121.465116.305198.373247.508620.45191.195107.866106.13256.41755.39886.85954.48645.34141.09553.356
Net Income Ratio 0.0910.1120.127-0.055-0.0110.0480.1570.184-0.10.1160.1590.1710.110.180.1420.2660.2970.3740.1530.1680.1720.0970.1080.150.10.0910.1010.122
EPS 0.130.150.15-0.063-0.0110.0460.20.33-0.150.210.250.160.140.190.180.310.390.980.140.170.250.0960.0950.150.0970.0810.0730.094
EPS Diluted 0.130.150.15-0.063-0.0110.0460.20.33-0.150.210.250.160.140.190.180.310.390.980.140.170.250.0960.0950.150.0970.0810.0730.094
EBITDA 105.25176.161127.70825.67316.38768.44104.798159.86225.901211.31193.882113.508110.415142.025159.227209.683269.304705.239131.308104.912160.225101.78973.514136.486109.17665.29658.999-0.267
EBITDA Ratio 0.1220.2120.1720.0350.0280.1120.1290.140.0280.1850.1950.190.1330.210.1940.2810.3230.4250.220.1640.260.1750.1430.2350.20.1320.145-0.001